1. Moderna heads to the FDA for an EUA for its COVID-19 vaccine — AstraZeneca plans extra trial for its COVID vaccine — Biogen bets $1.5B on Sage's failed depression drug — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Is the Madsen case a watershed for Nuvasive?

Discussion in 'NuVasive' started by anonymous, Mar 3, 2016 at 2:31 PM.

  1. anonymous

    anonymous Guest

  2. anonymous

    anonymous Guest

    GOOD FOR HER! It is about time the spine companies get hammered in court for poaching business.

    Couldn't happen to a sleazier industry! The whore surgeons should be next!

    Thanks doc for the one level L2-L3 fusion...should I schedule now for the revision and inevitable fusion(s) of all the adjacent levels?